Astrocytoma
2 papers
- Cells2
Trial sponsors
Novartis Pharmaceuticals Corporation
Company3 trialsPhase 4554 people
1 trialPhase 255 people
University of Vermont Medical Center
1 trialPhase 240 people
1 trialPhase 223 people
Washington University School of Medicine
1 trialPhase 26 people
1 trialPhase 186 people
1 trialPhase 128 people
1 trialPhase 118 people
Latest
1 in 12 monthsSignal Transduction and Targeted Therapy
Multi-omics dissection of MAPK-driven senescence unveils therapeutic vulnerabilities in KIAA1549::BRAF-fusion pediatric low-grade glioma models
Experiments in human cellsMAPK/ERK signalling
Molecular Neurobiology
Clusterin Deficiency Promotes Cellular Senescence in Human Astrocytes
Experiments in human cellsCellular senescence
Journal of Neuroinflammation
Microglia and astrocyte involvement in neurodegeneration and brain cancer
ReviewMechanisms
Acta Neuropathologica Communications
New somatic TERT promoter variants enhance the Telomerase activity in Glioblastoma
Study in peopleMechanisms
The New England Journal of Medicine
Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis
Non-randomized trial in 28 peoplemTOR inhibitors